CDXS - Codexis Revenue Growth YoY (Last 12 Months)

Brandmark of Codexis Inc (CDXS)

The primary driver for Codexis, Inc. (CDXS) is the synergy between its AI platform and elite biochemists. The YoY sales growth over the last four quarters visualizes this potential, where the value of 66.90 characterizes this level. The company's pricing power is based on proprietary enzymes, while cost optimization and a shift toward licensing under revamped management create the foundation for future growth.

Sales Growth YoY (TTM): Codexis, Inc. (CDXS) for 02/11/2024 - 11/15/2026

codexis.com - analytical breakdowns and key metrics (CDXS)

- share price and expert price forecast:
Share Price Codexis Bio|CDXS - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Codexis Bio|CDXS - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Net Assets per Share Codexis, Inc.|CDXS - Book Capitalization|Market Cap to Net Assets Ratio codexis.com|CDXS - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Ratio Codexis, Inc.|CDXS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Ratio Codexis, Inc.|CDXS - Company Debts|Debts to Net Assets Codexis|CDXS - Company Long-Term Debts|Company Short-Term Indebtedness Codexis, Inc.|Immediate Liquidity Ratio codexis.com
- company profitability and valuation multiples indicators:
CDXS - Net Profit|Projected Future Earnings Codexis, Inc.|CDXS - P/E Multiple|Projected Price to Earnings Codexis, Inc.|CDXS - Price/Earnings to Growth Ratio|Company Value to EBITDA Codexis|CDXS - Operating profit EBITDA|Earnings per share for the last 12 months Codexis, Inc.|CDXS - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months codexis.com|CDXS - Net earnings per share growth this year|Projected earnings per share growth rate for next year Codexis, Inc.
- sales revenue and business income indicators:
CDXS - Revenue and Sales Volume|Company Future Sales Codexis, Inc.|CDXS - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Codexis Bio|CDXS - Revenue Growth YoY (Last 12 Months)
Analysis of all company metrics:CDXS codexis.com
Flagship merchandise of Codexis, Inc.

This indicator measures the percentage change in revenue over the last twelve months relative to the same period last year, neutralizing seasonality to determine a sustainable vector of operational expansion. By analyzing the current year-over-year (TTM) sales dynamics, an investor assesses the effectiveness of Codexis, Inc. (CDXS) diversification across the biopharmaceutical and environmental segments through the commercialization rates of innovative enzyme products.

Who Codexis, Inc. competes with

Annual Revenue Growth (Last Twelve Months) Tempus AI, Inc (TEM)|QGEN: Revenue Growth YoY (Last 12 Months)|Ionis Pharmaceuticals (IONS) - Revenue Growth YoY (Last 12 Months)|Repligen (RGEN) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Avidity Biosciences, Inc.|Sales Growth YoY (Last Twelve Months) CRISPR Therapeutics|WGS - Revenue Growth Rate YoY (Last Twelve Months)|Sales Growth YoY (TTM) RARE|Revenue Change YoY (Last 12 Months) BEAM|Sales Growth YoY (TTM) SRPT (Sarepta Corp)|TWST - Revenue Growth YoY (Last 12 Months)|TXG: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Intellia Therapeutics|STOK: Sales Growth YoY (TTM)|BLFS - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) WVE|MAZE: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Sionna Corp (SION)|Annual Revenue Growth (Last Twelve Months) Prime Medicine Bio|Sales Growth YoY (TTM) TSHA (Taysha Gene Therapies Inc)|Sales Growth YoY (TTM) uniqure.com QURE|MeiraGTx Holdings - Sales Growth YoY (TTM)|RGNX - Sales Growth YoY (TTM)|SLDB (Solid Corp) - Revenue Growth YoY (Last 12 Months)|Revenue Growth Rate YoY (Last Twelve Months) Ocugen Corp OCGN|PACB (Pacific Biosciences) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BNTC|Sales Growth YoY (TTM) DSGN|Revenue Growth YoY (Last 12 Months) Rocket Pharma RCKT|Annual Revenue Growth (Last Twelve Months) FDMT|Sales Growth YoY (TTM) Lexeo Therapeutics LXEO|KRRO - Sales Growth YoY (Last Twelve Months)|EDIT (Editas Medicine, Inc.) - Sales Growth YoY (Last 12 Months)|SLN: Sales Growth YoY (TTM)|ProQR - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Sangamo BioSciences|Sales Growth YoY (Last 12 Months) NAUT (Nautilus Biotechnology)|Sales Growth YoY (Last Twelve Months) metagenomi.co (MGX)|DTIL: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Generation Bio Co. GBIO|BOLD: Sales Growth YoY (Last 12 Months)|XCUR: Revenue Growth YoY (Last 12 Months)|Imunon (IMNN) - Revenue Growth YoY (Last 12 Months)|PHIO (RXi Pharmaceuticals) - Revenue Growth YoY (Last 12 Months)|MBIO (Mustang Bio Inc) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) TransCode Therapeutics, Inc.|Sales Growth YoY (TTM) bionanogenomics.com|Sales Growth YoY (TTM) APDN|Sales Growth YoY (Last Twelve Months) BLUE (Bluebird Bio)|Sales Growth YoY (Last Twelve Months) ImmunoPrecise Antibodies Ltd. IPA|Revenue Dynamics YoY (Last Twelve Months) OMGA|singulargenomics.com - Sales Growth YoY (TTM)|Regulus Therapeutics Inc. - Revenue Change YoY (Last 12 Months)|SYRS: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TBIO|TCON (TRACON Pharmaceuticals) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) UBX (unitybiotechnology.com)